Common use of Brand Name Drugs Clause in Contracts

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-out- of-pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-of- pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay topay for a brand name instead of a generic drug will not be credited toward the out-out- of-pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay pay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a 9 bioequivalent generic drug is available, the subscriber is required to pay the 10 standard copayment plus the difference between the cost of the brand name drug 11 and the generic. Amounts above the copay that an individual elects to pay for a 12 brand name instead of a generic drug will not be credited toward the out-of-pocket 13 maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a 6 bioequivalent generic drug is available, the subscriber is required to pay the 7 standard copayment plus the difference between the cost of the brand name drug 8 and the generic. Amounts above the copay that an individual elects to pay for a 9 brand name instead of a generic drug will not be credited toward the out-of-pocket 10 maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for payfor a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket out‐of‐pocket maximum.

Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent 31 generic drug is available, the subscriber is required to pay the standard copayment plus the 1 difference between the cost of the brand name drug and the generic. Amounts above the 2 copay that an individual elects to pay for a brand name instead of a generic drug will not be 3 credited toward the out-of-pocket maximum.